期刊文献+

E钙黏着素与波形蛋白在膀胱癌中的表达及意义 被引量:4

The expression and significance of E-cadherin and Vimentin in transitional cell carcinoma of the bladder
下载PDF
导出
摘要 目的检测E钙黏着素(E-cadherin)和波形蛋白(Vimentin)在膀胱癌组织中表达及意义。方法采用免疫组织化学技术检测60例膀胱移行细胞癌组织中E-cadherin和Vimentin的表达,分析二者的相关性及其与膀胱癌病理分级的关系。结果E-cadherin和Vimentin在不同病理分级的膀胱癌组织中的表达差异有统计学意义(P<0.01),E-cadherin异常表达与Vimentin阳性表达成正相关(r=0.330,P<0.05)。结论初步证实在膀胱癌的发生、发展中可能存在上皮间质转化(EMT)现象;联合检测E-cadherin及Vimentin对判断膀胱癌患者的预后具有一定的临床价值。 Objective To detect the expression of E-cadherin and Vimentin and to discuss their significance for prognosis. Methods The expression of E-cadherin and Vimentin in 60 specimens of transitional cell carcinoma of the bladder was detected by SP immunohistochemistry. Results The expressions of both E-cadherin and Vimentin in three differentiated grades of transitional cell carcinoma of the bladder were statistically significant (both P 〈0. 01). There was a positive correlation between the abnormal expression of E-cadherin and the positive expression of Vimentin (r = 0. 330, P〈0.05).Conclusions This research indicated that there is epithelial-mesenchymal transition in the development of transitional cell carcinoma of bladder. The examination of both E-cadherin and Vimentin may be useful for the prognosis of bladder carcinoma.
出处 《现代泌尿外科杂志》 CAS 2010年第1期22-24,共3页 Journal of Modern Urology
关键词 膀胱癌 E钙黏着素 波形蛋白 免疫组织化学 bladder cancer E-cadherin Vimentin immunohistochemistry
  • 相关文献

参考文献8

  • 1MILLAN-RODRIQUEZ F, CHECHILE-TOMIOLO G, SAL VADOR-BAYARRI J, et al. Multivariate analysis of the prog nostic factors of primary superficial bladder cancer[J].J Urol, 2000, 163(1): 73-78.
  • 2BAUMGART E, COHEN MS, NETO BS, et al. Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors[J]. Clin Cancer Res,2007,13 (6): 1685-1694.
  • 3THIERY JP. Epithelial-mesenchymal transitions in tumour progression[J]. Currop in Cell Biol, 2003, 15 (6): 740-746.
  • 4AGNAN-TIS NJ, GOUSSIA AC, BATISTATOU A, et al. Tumormarkers in cancer patients an update of their prognostic significance. Partt II[J]. In Vivo, 2004,18 (4) : 481-488.
  • 5LANG SH, HYDE C, REID IN, et al. Enhanced expression of Vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma[J]. Prostate, 2002, 52 (4) : 253-263.
  • 6SINGH S, SADACHARAN S, SU S, et al. Overexpression of Vimentin:Role in the invasive phenotype in an androgen independent model of prostate cancer[J]. Cancer Res, 2003, 63 (9) : 2306-2311.
  • 7HWA JS, PARK HJ, JUNG JH, et al. Identification of proteins differentially expressed in the conventional renal cell carcinoma by proteomic analysis[J]. J Korean Med Sci, 2005, 20 (3): 450-455.
  • 8SABBAH M, EMAMI S, REDEUILH G, et al. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers[J]. Drug Resist Updat, 2008, 11(4-5): 123-151.

同被引文献28

  • 1孙翠云,王新允,李艳,刘婷,郑海燕,王爱香,赵敏,吴兴业.应用FISH和组织芯片方法研究肺癌组织Ets1 mRNA的表达及意义[J].肿瘤防治研究,2005,32(10):616-618. 被引量:2
  • 2Thiery Jean Paul. Epithelial - mesenchymal transitions in tumour progression [ J ]. Nature Reviews Cancer, 2002,2 : 442 - 454.
  • 3Sato M, Shames DS, Hasegawa Y. Emerging evidence of epithelial- to- mesenchymal transition in lung carcinogen- esis [ J ]. Respirology, 2012,17 : 1048 - 1059.
  • 4Yasuto Uehikado, Shoji Natsugoe, Hiroshi Okumura, et al. Slug expression in the E - cadherin preserved tumors is re- lated to prognosis in patients with esophageal squamous cell carcinoma[ J]. Cli Cancer Res ,2005,11 : 1174 - 1180.
  • 5Dandachi N, Hauser - Kronberger C, More E, et al. Co - expression of tenascin - c and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumor progression:correlation with histopathological param- eters, hormone receptors, and oncoproteins [ J ]. Pathol 2001,193(2) :181 - 189.
  • 6Liu D, Huang C, Kamceyama K, et al. E - cadherin expres- sion associated with differentiation and prognosis in patients with non - small cell lung cancer [ J ]. Ann Thorac Surg, 2001,71 (3) :949 - 954.
  • 7S A1 - Saad, K A1 - Shibli, Donnem T, et al. The prognostic impact of NF - Kappa B p105, vimentin, E - cadherin and Par6 expression in epithelial and stromal compartment in non- small cell lung cancer [ J ]. Br J Cancer, 2008,99 (9) :1476 - 1483.
  • 8Robert L Yauch, Thomas Januario, David A Eberhard, et al. Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients [ J ]. Clin Cancer Res, 2005, 11: 8686 - 8698.
  • 9Miyanaga A, Gemma A, Ando M, et al. E - cadherin espression and epidermal growth factor receptor mutation status predict outcome in non - small cell lung cancer pa- tients treated with gefitinib [ J ]. Oncol Rep, 2008, 19 : 377 - 383.
  • 10翟明翠.N-cadherin与nm23-H1在乳腺癌中的表达及意义[J].黑龙江医学,2010,34(8):561-563. 被引量:1

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部